Micronomicin
Chemical compound
- S01AA22 (WHO)
- In general: ℞ (Prescription only)
- (1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-α-D-erythro-hexopyranoside
- 52093-21-7
- 107677
- 2301017
- S9AZ0R40QV
- D08219 Y
- DTXSID401023736
- Interactive image
- C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H](C([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CNC)N)N)N)O
InChI
- InChI=1S/C20H41N5O7/c1-20(28)8-29-19(14(27)17(20)25-3)32-16-12(23)6-11(22)15(13(16)26)31-18-10(21)5-4-9(30-18)7-24-2/h9-19,24-28H,4-8,21-23H2,1-3H3/t9-,10+,11-,12+,13-,14+,15+,16-,17+,18+,19+,20-/m0/s1
- Key:DNYGXMICFMACRA-XHEDQWPISA-N
Micronomicin (INN) is an aminoglycoside antibiotic for use on the eye.[1][2]
References
- ^ Odakura Y, Kase H, Nakayama K (February 1983). "Sagamicin and the related aminoglycosides: fermentation and biosynthesis. III. Isolation and characterization of Micromonospora sagamiensis mutants blocked in gentamicin C1 pathway". The Journal of Antibiotics. 36 (2): 125–30. doi:10.7164/antibiotics.36.125. PMID 6833127.
- ^ Fukuda M, Sasaki K (April 2002). "[Antibiotic ophthalmic solutions evaluated by pharmacokinetic parameters of maximum concentration in the aqueous]". Nippon Ganka Gakkai Zasshi. 106 (4): 195–200. PMID 11979978.
- v
- t
- e
Aminoglycosides (initiation inhibitors) |
| ||||||
---|---|---|---|---|---|---|---|
Tetracycline antibiotics (tRNA binding) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e